United Services Automobile Association Immuno Gen, Inc. Transaction History

United Services Automobile Association

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$2.22 - $3.39 $50,937 - $77,783	-22,945 Closed	0 $0
Q2 2018 Sep 27, 2018	BUY	$9.52 - $12.15 $71,390 - $91,112	7,499 Added 48.55%	22,945 $223,000
Q2 2018 Aug 10, 2018	SELL	$9.52 - $12.15 $9,938 - $12,684	-1,044 Reduced 6.33%	15,446 $728,000
Q1 2018 May 14, 2018	BUY	$6.7 - $12.95 $110,483 - $213,545	16,490 New	16,490 $173,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.